INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 58 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,000 | 0.0% | 4,968 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | -25.0% | 4,968 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | -42.9% | 4,968 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | -74.1% | 4,968 | -55.1% | 0.00% | – |
| Q2 2017 | $27,000 | -18.2% | 11,056 | +40.9% | 0.00% | – |
| Q1 2017 | $33,000 | +17.9% | 7,848 | +27.7% | 0.00% | – |
| Q4 2016 | $28,000 | +3.7% | 6,148 | +63.2% | 0.00% | – |
| Q3 2016 | $27,000 | +8.0% | 3,768 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | +31.6% | 3,768 | 0.0% | 0.00% | – |
| Q1 2016 | $19,000 | -45.7% | 3,768 | -0.7% | 0.00% | -100.0% |
| Q4 2015 | $35,000 | -2.8% | 3,793 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $36,000 | -23.4% | 3,793 | +10.2% | 0.00% | 0.0% |
| Q2 2015 | $47,000 | – | 3,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|